BIO Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (BIO) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $539.9K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| ENLOE COURTNEY C | EVP, General Counsel & Sec | Sell | 902 | $386.17 | $348.3K | 750 −54.6% of holding | |
| BARRY JAMES | EVP, President, LSG | Sell | 1,400 | $385.63 | $539.9K | 625 −69.1% of holding | |
| DiVincenzo Jonathan P. | President & COO | Sell | 919 | $390.47 | $358.8K | 1,962 −31.9% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.